Description:

ODM derived from http://clinicaltrials.gov/show/NCT00321620

Link:
http://clinicaltrials.gov/show/NCT00321620
Keywords:
  1. 3/20/12 3/20/12 -
  2. 3/20/12 3/20/12 -
  3. 4/14/14 4/14/14 - Julian Varghese
  4. 4/20/14 4/20/14 - Julian Varghese
  5. 9/20/21 9/20/21 -
Uploaded on:

September 20, 2021

DOI:
To request one please log in.
License :
Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility DRKS00009676 NCT00321620 Bone Metastases

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Age 18 Years and older
Men >/= 18 years of age with histologically confirmed prostate cancer
Radiographic evidence of at least one bone metastasis
Failure of at least one hormonal therapy as evidenced by a rising PSA
Serum testosterone level of <50 ng/dL
ECOG performance 0,1 or 2
Adequate organ function
Exclusion Criteria
Current or prior IV bisphosphonate administration
Current or prior oral bisphosphonates for bone mets
life expectancy <6 months

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial